Sulphonamide inhibition studies of the β-carbonic anhydrase GsaCAβ present in the salmon platyhelminth parasite Gyrodactylus salaris
暂无分享,去创建一个
C. Supuran | S. Parkkila | C. Primmer | A. Aspatwar | Alessandro Bonardi | J. Lumme | Heidi Aisala | Ksenia J Zueva
[1] C. Supuran. Carbonic Anhydrase Inhibitors from Marine Natural Products , 2022, Marine drugs.
[2] C. Supuran,et al. May Sulfonamide Inhibitors of Carbonic Anhydrases from Mammaliicoccus sciuri Prevent Antimicrobial Resistance Due to Gene Transfer to Other Harmful Staphylococci? , 2022, International journal of molecular sciences.
[3] C. Supuran,et al. Activation studies with amino acids and amines of a β-carbonic anhydrase from Mammaliicoccus (Staphylococcus) sciuri previously annotated as Staphylococcus aureus (SauBCA) carbonic anhydrase , 2022, Journal of enzyme inhibition and medicinal chemistry.
[4] C. Supuran. Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities , 2022, Journal of enzyme inhibition and medicinal chemistry.
[5] C. Supuran,et al. Inhibition studies of the protozoan α-carbonic anhydrase from Trypanosoma cruzi with phenols , 2022, Journal of enzyme inhibition and medicinal chemistry.
[6] A. Da'dara,et al. Schistosoma mansoni and the purinergic halo. , 2022, Trends in parasitology.
[7] C. Supuran,et al. Seleno Containing Compounds as Potent and Selective Antifungal Agents , 2022, ACS infectious diseases.
[8] C. Supuran,et al. Sulfonamide Diuretic Azosemide as an Efficient Carbonic Anhydrase Inhibitor , 2022, Journal of Molecular Structure.
[9] S. C. Chafe,et al. Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside , 2022, Cancers.
[10] C. Supuran,et al. Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases , 2022, Journal of enzyme inhibition and medicinal chemistry.
[11] N. Delanty,et al. Acetazolamide: Old drug, new evidence? , 2022, Epilepsia open.
[12] C. Supuran,et al. Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris , 2022, Journal of enzyme inhibition and medicinal chemistry.
[13] J. Keiser,et al. Development of Praziquantel sulphonamide derivatives as antischistosomal drugs , 2022, Journal of enzyme inhibition and medicinal chemistry.
[14] A. Da'dara,et al. NAD-catabolizing ectoenzymes of Schistosoma mansoni. , 2022, Biochemical Journal.
[15] S. Carradori,et al. Inhibition of Schistosoma mansoni carbonic anhydrase by the antiparasitic drug clorsulon: X-ray crystallographic and in vitro studies , 2022, Acta crystallographica. Section D, Structural biology.
[16] W. Sly,et al. Carbonic Anhydrases in Metazoan Model Organisms: Molecules, Mechanisms, and Physiology. , 2022, Physiological reviews.
[17] C. Supuran,et al. Coumarins effectively inhibit bacterial α-carbonic anhydrases , 2022, Journal of enzyme inhibition and medicinal chemistry.
[18] A. Scaloni,et al. Heterologous expression and biochemical characterisation of the recombinant β-carbonic anhydrase (MpaCA) from the warm-blooded vertebrate pathogen malassezia pachydermatis , 2021, Journal of enzyme inhibition and medicinal chemistry.
[19] C. Supuran,et al. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae , 2021, Journal of enzyme inhibition and medicinal chemistry.
[20] C. Supuran. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors , 2021, Expert opinion on investigational drugs.
[21] A. Da'dara,et al. Schistosome immunomodulators , 2021, PLoS pathogens.
[22] C. Cerri,et al. Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives , 2021, Molecules.
[23] C. Supuran,et al. Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis , 2021, Journal of molecular medicine.
[24] Claudiu T Supuran,et al. Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets. , 2021, Future medicinal chemistry.
[25] S. C. Chafe,et al. Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors , 2021, Science advances.
[26] C. Supuran,et al. Structural Insights into Schistosoma mansoni Carbonic Anhydrase (SmCA) Inhibition by Selenoureido-Substituted Benzenesulfonamides. , 2021, Journal of medicinal chemistry.
[27] C. Supuran. Emerging role of carbonic anhydrase inhibitors. , 2021, Clinical science.
[28] C. Supuran,et al. Advances in the discovery of novel agents for the treatment of glaucoma , 2021, Expert opinion on drug discovery.
[29] C. Supuran,et al. A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium , 2021, International journal of molecular sciences.
[30] J. Kaur,et al. Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae. , 2021, ACS infectious diseases.
[31] C. B. Mishra,et al. Discovery of Potent Carbonic Anhydrase Inhibitors as Effective Anticonvulsant Agents: Drug Design, Synthesis, and In Vitro and In Vivo Investigations. , 2021, Journal of medicinal chemistry.
[32] J. Bron,et al. Geographical distribution of Gyrodactylus salaris Malmberg, 1957 (Monogenea, Gyrodactylidae) , 2021, Parasites & vectors.
[33] C. Supuran. Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders , 2021, Journal of enzyme inhibition and medicinal chemistry.
[34] S. Carradori,et al. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase , 2021, Journal of enzyme inhibition and medicinal chemistry.
[35] S. Carradori,et al. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment , 2020, Metabolites.
[36] C. Supuran,et al. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature , 2020, Expert opinion on therapeutic patents.
[37] C. B. Mishra,et al. Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? , 2020, Medicinal research reviews.
[38] C. Supuran,et al. Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand/Isoform Matching and Selectivity of Action , 2020, Journal of medicinal chemistry.
[39] C. Supuran,et al. Sulfonamide Inhibition Studies of an α-Carbonic Anhydrase from Schistosoma mansoni, a Platyhelminth Parasite Responsible for Schistosomiasis , 2020, International journal of molecular sciences.
[40] C. Supuran,et al. Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA , 2019, Communications Biology.
[41] C. Supuran. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors , 2018, Expert opinion on investigational drugs.
[42] Alexa J. Lamm,et al. Acetazolamide promotes decreased consumption of carbonated drinks and weight loss , 2018, Oxford medical case reports.
[43] C. Supuran. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas , 2018, Expert opinion on therapeutic patents.
[44] C. Supuran. Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases , 2018, Expert opinion on therapeutic patents.
[45] C. B. Mishra,et al. Discovery of potent anti-convulsant carbonic anhydrase inhibitors: Design, synthesis, in vitro and in vivo appraisal. , 2018, European journal of medicinal chemistry.
[46] M. Kent,et al. Genomic signatures of parasite-driven natural selection in north European Atlantic salmon (Salmo salar). , 2018, Marine genomics.
[47] C. Supuran. Carbonic Anhydrases and Metabolism , 2018, Metabolites.
[48] H. Hansen,et al. Infections with Gyrodactylus spp. (Monogenea) in Romanian fish farms: Gyrodactylus salaris Malmberg, 1957 extends its range , 2016, Parasites & Vectors.
[49] C. Supuran,et al. Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis , 2015, Parasites & Vectors.
[50] C. Supuran,et al. Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests , 2015, Journal of enzyme inhibition and medicinal chemistry.
[51] Harlan R. Barker,et al. Beta carbonic anhydrases: novel targets for pesticides and anti-parasitic agents in agriculture and livestock husbandry , 2014, Parasites & Vectors.
[52] P. D. Harris,et al. Same barcode, different biology: differential patterns of infectivity, specificity and pathogenicity in two almost identical parasite strains. , 2014, International journal for parasitology.
[53] C. Supuran,et al. Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. , 2013, Journal of medicinal chemistry.
[54] C. Supuran,et al. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. , 2012, Journal of medicinal chemistry.
[55] C. Supuran,et al. Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids , 2010, Chemical biology & drug design.
[56] B. Schelkle,et al. Treatment of gyrodactylid infections in fish. , 2009, Diseases of aquatic organisms.
[57] Claudiu T Supuran,et al. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. , 2008, Bioorganic & medicinal chemistry letters.
[58] Claudiu T. Supuran,et al. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.
[59] J. Utzinger,et al. Drugs for treating urinary schistosomiasis , 2014, The Cochrane database of systematic reviews.
[60] C. Supuran,et al. Inhibition of the archaeal beta-class (Cab) and gamma-class (Cam) carbonic anhydrases. , 2007, Current Topics in Medicinal Chemistry.
[61] C. Supuran,et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. , 2006, Journal of medicinal chemistry.
[62] C. Supuran,et al. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. , 2004, Bioorganic & medicinal chemistry letters.
[63] S. Krungkrai,et al. Plasmodium falciparum Carbonic Anhydrase is a Possible Target for Malaria Chemotherapy , 2004, Journal of enzyme inhibition and medicinal chemistry.
[64] Christopher C. E. Hopkins,et al. Introduced Marine Organisms in Norwegian Waters, Including Svalbard , 2002 .
[65] L. Chitsulo,et al. Therapeutic and Operational Profiles of Metrifonate and Praziquantel in Schistosoma haematobium Infection , 1999, Arzneimittelforschung.
[66] T. Bakke,et al. Aqueous aluminium eliminates Gyrodactylus salaris (Platyhelminthes, Monogenea) infections in Atlantic salmon , 1999, Parasitology.
[67] C. Supuran,et al. Carbonic anhydrase inhibitors - Part 57 : Quantum chemical QSAR of a group of 1,3,4-thiadiazole- and 1,3,4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties , 1999 .
[68] G. Schmahl. The chemotherapy of monogeneans which parasitize fish: a review. , 1991, Folia parasitologica.
[69] R. Khalifah,et al. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.